Clinical Trial Update: Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating daptomycin in elderly patients with complicated skin and soft tissue infections has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Soft Tissue Infections

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Infections | Phase 3 | Status: COMPLETED | Results posted: 2012-04-18